Literature DB >> 17924777

Progesterone: review of safety for clinical studies.

Nathalie V Goletiani1, Diana R Keith, Sara J Gorsky.   

Abstract

Progesterone is a steroid hormone that is important for reproductive function. Progesterone is used in a number of clinical applications and has been investigated as a possible novel approach for treatment of stimulant drug abuse. Extensive clinical studies have been conducted to examine the subjective and physiological effects of exogenous progesterone administration and to evaluate its side effects. This review summarizes the safety and side effects of acute and chronic administration of 3 progesterone formulations (synthetic, natural, and micronized natural), several routes of administration (oral, intramuscular, intravenous, intravaginal, intranasal, transdermal, and rectal), and dosing regimens. Synthetic progestins marketed as Provera, PremPro, and Cycrin are widely used but may produce a number of significant side effects, such as fatigue, fluid retention, lipid level alterations, dysphoria, hypercoagulant states, and increased androgenicity. Natural progesterones are reported to have milder adverse effects, depending on the route of administration. Micronized natural progesterone is available for oral administration, has better bioavailability and fewer side effects than natural progesterone, and is convenient to administer. Therefore, micronized natural progesterone appears to be a safe and effective alternative to synthetic and natural progesterone formulations for variety of clinical and research applications. (c) 2007 APA

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17924777     DOI: 10.1037/1064-1297.15.5.427

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  12 in total

Review 1.  Potential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.

Authors:  Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-01

Review 2.  Vascular effects of estrogenic menopausal hormone therapy.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Rev Recent Clin Trials       Date:  2012-02

Review 3.  Progesterone treatment for experimental stroke: an individual animal meta-analysis.

Authors:  Raymond Wong; Cheryl Renton; Claire L Gibson; Stephanie J Murphy; David A Kendall; Philip M W Bath
Journal:  J Cereb Blood Flow Metab       Date:  2013-07-10       Impact factor: 6.200

4.  Progesterone for smoking relapse prevention following delivery: A pilot, randomized, double-blind study.

Authors:  Ariadna Forray; Kathryn Gilstad-Hayden; Cristine Suppies; Debra Bogen; Mehmet Sofuoglu; Kimberly A Yonkers
Journal:  Psychoneuroendocrinology       Date:  2017-09-14       Impact factor: 4.905

5.  Effects of progesterone and testosterone on cocaine self-administration and cocaine discrimination by female rhesus monkeys.

Authors:  Nancy K Mello; Inge M Knudson; Maureen Kelly; Peter A Fivel; Jack H Mendelson
Journal:  Neuropsychopharmacology       Date:  2011-07-27       Impact factor: 7.853

Review 6.  Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.

Authors:  Dia A Smiley; Raouf A Khalil
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 7.  [Progress on evaluation, diagnosis and management of disorders of sex development].

Authors:  Guangjie Chen; Xiaohao Wang; Daxing Tang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2019-06-25

8.  Clinical profile of 93 cases of 46, XY disorders of sexual development in a referral center.

Authors:  Bianca Costa Mota; Luciana Mattos Barros Oliveira; Renata Lago; Paula Brito; Ana Karina Canguçú-Campinho; Ubirajara Barroso; Maria Betânia Pereira Toralles
Journal:  Int Braz J Urol       Date:  2015 Sep-Oct       Impact factor: 1.541

Review 9.  The Role Of Progestogens In Threatened And Idiopathic Recurrent Miscarriage.

Authors:  Hisham Arab; Ahmed Jaber Alharbi; Ayman Oraif; Emad Sagr; Hana Al Madani; Hassan Abduljabbar; Osama Sadeak Bajouh; Yaser Faden; Yasser Sabr
Journal:  Int J Womens Health       Date:  2019-11-07

10.  Vaginal progesterone in risk reduction of preterm birth in women with short cervix in the midtrimester of pregnancy.

Authors:  Meena Khandelwal
Journal:  Int J Womens Health       Date:  2012-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.